-

Trinity Life Sciences Offers Pharma Industry’s First and Only Benchmarking-based Launch Planning Solution

Approach is Deeply Rooted in Real Drug Launch Experience to Empower Superior Commercialization Readiness Planning

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, announces the pharma industry’s first and only benchmarking-based launch planning offering. The Trinity Launch Planning Solution is deeply rooted in real drug launch experience to empower superior commercialization readiness.

Through proprietary technology, Trinity launch experts can quickly pull best practices from past effective launches of treatments in a specific therapeutic area based on unique benchmarking data. This allows Trinity to start with a solid base launch plan from day one, allowing more time to be spent on collaborating with cross-functional pharma launch teams on customized nuances for the plan.

“Our exclusive technology, powered by our in-depth benchmarking data and in-house expertise, gives pharma executives confidence in their launch plan. Every task is specifically considered for a drug launch based on best practices of past successful launches and then further enhanced by our Trinity launch experts,” said Krista Perry, Principal – Head of Launch Excellence, Trinity. “Our best-in-class launch planning is a direct result of working with our world class TGaS benchmarking division, making our Trinity solution unlike anything else available on the market today.”

Ideal for building/refining a plan, pressure-testing an existing plan for gaps or providing project management office (PMO) support, clients can access their plans directly from Trinity’s easy-to-use project management platform, Launch Accelerator. Collaboration and communication are streamlined with Gantt charts, dashboards and reports generated from the Launch Accelerator, all of which can be customized and configured by Trinity launch experts or by a pharma company’s in-house launch team.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

More News From Trinity Life Sciences

Trinity Life Sciences’ AI Algorithm Accurately Predicts Revenue Outcomes for Over 90% of U.S. Drug Launches Far Exceeding Wall Street Analyst Attempts

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, introduced its artificial intelligence (AI) algorithm which accurately predicted revenue outcomes for over 90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%). Trinity’s latest white paper in its Industry Impact Series, titled Predicting Winners: AI-Powered Portfolio Management, explores the use...

Health Equity Considerations as a Differentiator in Value Narratives Provide Opportunity for Life Sciences’ Global HTA Submissions

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces a dedicated Value Center of Excellence (COE) that provides end-to-end partnership along the value journey to Market Access and Health Economics and Outcomes Research (HEOR) teams, from strategy to communication. The COE approaches U.S. and global value work through a uniquely integrated combination of market access and HEOR expertise. Trinity’s Value C...

Analysis of Disparate Health Technology Assessment Landscape Transformed With Generative AI Tools

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, today announces an enhancement to its HTA Vision offering that swiftly extracts relevant information from health technology assessments (HTAs) and Trinity expert analyses, streamlining the information-gathering process within any therapeutic area or drug class. By not only locating but also summarizing key information with generative AI (GenAI), HTA Vision trans...
Back to Newsroom